Showing results (321-330 of 384) with videos related to
Sort By:
Pageof 39
BJU International|April 16, 2014
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk featureFarzana A Faisal, Debasish Sundi, Phillip M Pierorazio, et al.Implementation Science Communications|October 29, 2021
Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.The Journal of Urology|April 17, 2002
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancerKoji Okihara, Carol D Cheli, Alan W Partin, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.The Journal of Molecular Diagnostics : JMD|December 6, 2016
Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory SettingParvez M Lokhandwala, Stacy L Riel, Lisa Haley, et al.Pageof 39